GR3033593T3 - Pharmaceutical preparation controlled to release medicinal active ingredient at targeted site in intestinal tract. - Google Patents

Pharmaceutical preparation controlled to release medicinal active ingredient at targeted site in intestinal tract.

Info

Publication number
GR3033593T3
GR3033593T3 GR20000401161T GR20000401161T GR3033593T3 GR 3033593 T3 GR3033593 T3 GR 3033593T3 GR 20000401161 T GR20000401161 T GR 20000401161T GR 20000401161 T GR20000401161 T GR 20000401161T GR 3033593 T3 GR3033593 T3 GR 3033593T3
Authority
GR
Greece
Prior art keywords
active ingredient
medicinal active
targeted site
pharmaceutical preparation
intestinal tract
Prior art date
Application number
GR20000401161T
Other languages
English (en)
Inventor
Yoshiyuki Hirakawa
Hiroyuki Yoshino
Eiji Fukui
Tami Hanamori
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=12593695&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR3033593(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Publication of GR3033593T3 publication Critical patent/GR3033593T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GR20000401161T 1994-03-11 2000-06-01 Pharmaceutical preparation controlled to release medicinal active ingredient at targeted site in intestinal tract. GR3033593T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6040911A JP2917799B2 (ja) 1994-03-11 1994-03-11 消化管内適所放出型製剤

Publications (1)

Publication Number Publication Date
GR3033593T3 true GR3033593T3 (en) 2000-09-29

Family

ID=12593695

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20000401161T GR3033593T3 (en) 1994-03-11 2000-06-01 Pharmaceutical preparation controlled to release medicinal active ingredient at targeted site in intestinal tract.

Country Status (14)

Country Link
US (1) US5725880A (el)
EP (1) EP0671168B1 (el)
JP (1) JP2917799B2 (el)
KR (1) KR100305234B1 (el)
CN (1) CN1116523A (el)
AT (1) ATE193439T1 (el)
CA (1) CA2144094C (el)
DE (1) DE69517218T2 (el)
DK (1) DK0671168T3 (el)
ES (1) ES2148365T3 (el)
GR (1) GR3033593T3 (el)
PT (1) PT671168E (el)
SG (1) SG34210A1 (el)
TW (1) TW422708B (el)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2120354B1 (es) * 1996-02-12 1999-07-01 Univ Sevilla Dispositivo terapeutico para direccionar farmacos hacia el tramo del tracto gastrointestinal deseado en funcion de las caracteristicas fisicoquimicas del mismo.
DE19732903A1 (de) 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
IN186245B (el) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
DE69924735T2 (de) 1998-07-28 2006-01-19 Tanabe Seiyaku Co., Ltd. Zur wirkstoffabgabe an zielorten im darm fähige zubereitung
JP2002535353A (ja) 1999-01-29 2002-10-22 ロザン ファルマ ゲゼルシャフトミットベシュレンクテルハフツンク 医薬品組成物
FR2790387B1 (fr) * 1999-03-01 2001-05-18 Prographarm Laboratoires Comprime orodispersible presentant une faible friabilite et son procede de preparation
US6270807B1 (en) 1999-03-02 2001-08-07 L. Perrigo Company Taste-masked pharmaceutical composition
US6245913B1 (en) 1999-06-30 2001-06-12 Wockhardt Europe Limited Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole
CA2398555C (en) * 2000-01-27 2008-04-22 Tanabe Seiyaku Co., Ltd. Sustained release preparation and method for producing the same
US6420473B1 (en) 2000-02-10 2002-07-16 Bpsi Holdings, Inc. Acrylic enteric coating compositions
KR20030025903A (ko) * 2000-02-10 2003-03-29 비피에스아이 홀딩스, 인코포레이션. 아크릴 장용 코팅 조성물
IT1318625B1 (it) * 2000-07-14 2003-08-27 Roberto Valducci Formulazioni farmaceutiche solide orali a rilascio multifasicoph-dipendente.
AU4061702A (en) * 2001-05-15 2003-04-03 Mcneil-Ppc, Inc. Dip coating compositions containing starch or dextrin
US20030070584A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
US20030072731A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing starch or dextrin
US8309118B2 (en) * 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
US7429619B2 (en) * 2002-08-02 2008-09-30 Mcneil Consumer Healthcare Polyacrylic film forming compositions
US20040185093A1 (en) * 2003-03-18 2004-09-23 Szymczak Christopher E. Compositions containing sucralose
US20060188563A1 (en) * 2003-03-27 2006-08-24 Hisamitsu Pharmaceutical Co., Inc. Medicinal oral preparations for colon delivery, medicinal oral preparations for treating colon cancer and medicinal oral preparations for treating colitis
US8916546B2 (en) 2003-08-29 2014-12-23 Therapeutic Research Llc Materials and methods for treatment and diagnosis of disorders associated with oxidative stress
GB0320522D0 (en) * 2003-09-02 2003-10-01 Glaxo Group Ltd Formulation
GB0400452D0 (en) * 2004-01-09 2004-02-11 Norton Healthcare Ltd A pharmaceutical composition
US20060024368A1 (en) * 2004-07-30 2006-02-02 Reza Fassihi Compressed composite delivery system for release-rate modulation of bioactives
US20060062811A1 (en) * 2004-09-21 2006-03-23 Szymczak Christopher E Medicinal cooling emulsions
JPWO2007010846A1 (ja) * 2005-07-15 2009-01-29 キッセイ薬品工業株式会社 胃内滞留製剤
EP1913138B1 (en) 2005-07-29 2016-08-24 Abbott Laboratories GmbH Processes for the manufacture of pancreatin powder with low virus content
US9198871B2 (en) * 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
SI1931316T2 (sl) 2005-08-15 2017-05-31 Abbott Laboratories Gmbh Farmacevtski sestavki z nadzorovanim sproščanjem za kislinsko labilna zdravila
US11266607B2 (en) * 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
US10072256B2 (en) * 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
WO2008087882A1 (ja) * 2007-01-15 2008-07-24 Kissei Pharmaceutical Co., Ltd. 胃内滞留型レボドパ徐放性製剤
US20100303901A1 (en) * 2007-04-26 2010-12-02 Eyal Shimoni Oral delivery of proteins and peptides
MX2009013683A (es) * 2007-06-13 2010-04-07 Jay Pravda Materiales y metodos para el tratamiento y diagnostico de trastornos asociados con estres oxidativo.
US20090036414A1 (en) * 2007-08-02 2009-02-05 Mutual Pharmaceutical Company, Inc. Mesalamine Formulations
US20090130063A1 (en) * 2007-11-15 2009-05-21 Solvay Pharmaceuticals Gmbh Process for separating and determining the viral load in a pancreatin sample
EP2334178A4 (en) 2008-10-03 2012-04-11 Falk Pharma Gmbh COMPOSITIONS AND METHODS OF TREATING THERAPEUTIC DISEASES WITH GRANULATED MESALAMINE
EP2255794A1 (en) * 2009-05-29 2010-12-01 H e x a l Aktiengesellschaft Enteric coating
JP5496616B2 (ja) * 2009-11-18 2014-05-21 フロイント産業株式会社 大腸ドラッグデリバリーシステム製剤
CA3050082A1 (en) 2016-04-04 2017-10-12 Omeza LLC Fish oil topical composition
EP3749289A4 (en) * 2018-02-06 2021-11-17 Robert Niichel MULTI-PARTICULAR PRODUCT CONTAINING ACTIVE PHARMACEUTICAL OR PROBIOTIC SUBSTANCES
MX2024000522A (es) * 2021-07-09 2024-02-02 Evonik Operations Gmbh Composicion que comprende un copolimero de (met)acrilato, una sal alcalina o de amonio de un acido monocarboxilico alifatico saturado y deslizantes especificos.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3325365A (en) * 1963-04-02 1967-06-13 Ciba Geigy Corp Enteric composition for tablet compression coating
US3608030A (en) * 1969-05-21 1971-09-21 Howard Tint Method of preparing a tablet dosage-form for the immunization of the intestinal tract with live virus preparations
GB1456365A (en) * 1972-10-06 1976-11-24 Gist Brocades Nv Controlled release composition
CA1308357C (en) * 1987-01-28 1992-10-06 Tohru Chiba Method for the preparation of a coated solid medicament
JP2773959B2 (ja) * 1990-07-10 1998-07-09 信越化学工業株式会社 大腸内放出性固形製剤
US5162117A (en) * 1991-11-22 1992-11-10 Schering Corporation Controlled release flutamide composition

Also Published As

Publication number Publication date
CA2144094C (en) 2004-01-27
KR100305234B1 (ko) 2002-04-24
EP0671168B1 (en) 2000-05-31
ES2148365T3 (es) 2000-10-16
JP2917799B2 (ja) 1999-07-12
ATE193439T1 (de) 2000-06-15
JPH07247222A (ja) 1995-09-26
CN1116523A (zh) 1996-02-14
TW422708B (en) 2001-02-21
DK0671168T3 (da) 2000-08-07
KR950031046A (ko) 1995-12-18
EP0671168A1 (en) 1995-09-13
SG34210A1 (en) 1996-12-06
DE69517218D1 (de) 2000-07-06
US5725880A (en) 1998-03-10
PT671168E (pt) 2000-09-29
DE69517218T2 (de) 2000-11-30
CA2144094A1 (en) 1995-09-12

Similar Documents

Publication Publication Date Title
SG34210A1 (en) Pharmaceutical preparation controlled to release medicinal active ingredient at targeted site in intestinal tract
MX9500885A (es) Preparacion farmaceutica para administracion oral.
ATE205705T1 (de) Arzneimittel zum wirkstoff - targetting in den dickdarm
WO1998056360A3 (en) Film-coated tablet for improved upper gastrointestinal tract safety
HU9302379D0 (en) Peroral medical preparatives with retarded releasing of active agents for treating intestinal diseases
HK1035492A1 (en) Devices for providing prolonged drug therapy.
WO2007079082A3 (en) Gastric release pulse system for drug delivery
NO20003640L (no) Ny doseringsform
NZ237516A (en) Device for drug delivery to intestinal tract comprising a core of active ingredient together with osmotically activated expulsion agent and an outer coating containing a hydrophobic material to assist in delaying release
NO940376L (no) Doseringsanordning for avgivelse av medikament over et tidsrom med kort varighet
DK0621032T3 (da) Lægemiddelform med reguleret afgivelse
SG80553A1 (en) Pharmaceutical preparation in form of coated capsule releasable at lower part of digestive tract
RU2227033C2 (ru) Тауролидин и/или таурултам при лечении инфекционной язвенной болезни или инфекционного гастрита
WO1998026767A3 (en) Site-specific controlled release dosage formulation for mesalamine
CA2032475A1 (en) Pharmaceutical preparations for oral administration that are adapted to release the drug at appropriate sites in the intestines
EP0271151A3 (en) Azumolene dosage form
JP2001514218A5 (el)
RU2001131112A (ru) Препаративная форма для введения в подвздошную кишку, включающая соединение, ингибирующее транспорт подвздошнокишечной желчной кислоты
IL122719A (en) Controlled release pharmaceutical dosage forms for oral administration containing nifedipine as active substance and process for their preparation

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees